These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Seizures and epilepsy in multiple sclerosis, aquaporin 4 antibody-positive neuromyelitis optica spectrum disorder, and myelin oligodendrocyte glycoprotein antibody-associated disease. Li EC; Zheng Y; Cai MT; Lai QL; Fang GL; Du BQ; Shen CH; Zhang YX; Wu LJ; Ding MP Epilepsia; 2022 Sep; 63(9):2173-2191. PubMed ID: 35652436 [TBL] [Abstract][Full Text] [Related]
24. Differentiated pattern of complement system activation between MOG-IgG-associated disease and AQP4-IgG-positive neuromyelitis optica spectrum disorder. Cho EB; Min JH; Waters P; Jeon M; Ju ES; Kim HJ; Kim SH; Shin HY; Kang SY; Lim YM; Oh SY; Lee HL; Sohn E; Lee SS; Oh J; Kim S; Huh SY; Cho JY; Seok JM; Kim BJ; Kim BJ Front Immunol; 2024; 15():1320094. PubMed ID: 38576611 [TBL] [Abstract][Full Text] [Related]
25. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 3: Brainstem involvement - frequency, presentation and outcome. Jarius S; Kleiter I; Ruprecht K; Asgari N; Pitarokoili K; Borisow N; Hümmert MW; Trebst C; Pache F; Winkelmann A; Beume LA; Ringelstein M; Stich O; Aktas O; Korporal-Kuhnke M; Schwarz A; Lukas C; Haas J; Fechner K; Buttmann M; Bellmann-Strobl J; Zimmermann H; Brandt AU; Franciotta D; Schanda K; Paul F; Reindl M; Wildemann B; J Neuroinflammation; 2016 Nov; 13(1):281. PubMed ID: 27802825 [TBL] [Abstract][Full Text] [Related]
26. Clinical and radiographic features of a cohort of adult and pediatric subjects in the Pacific Northwest with myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD). Martin K; Srikanth P; Kanwar A; Falardeau J; Pettersson D; Yadav V Mult Scler Relat Disord; 2024 Jan; 81():105130. PubMed ID: 37979410 [TBL] [Abstract][Full Text] [Related]
28. [Clinical analysis of neuromyelitis optica spectrum disorders in childhood]. Zhou J; Zhang Y; Ji TY; Jin YW; Bao XH; Zhang YH; Xiong H; Chang XZ; Jiang YW; Wu Y Zhonghua Er Ke Za Zhi; 2019 Feb; 57(2):118-124. PubMed ID: 30695886 [No Abstract] [Full Text] [Related]
29. Clinical and radiological profile of neuromyelitis optica spectrum disorders in a Pakistani cohort. Rajput HM; Hassan M; Badshah M Mult Scler Relat Disord; 2023 Jun; 74():104656. PubMed ID: 37068371 [TBL] [Abstract][Full Text] [Related]
30. Cerebrospinal fluid eosinophils in pediatric myelin oligodendrocyte glycoprotein antibody-associated disease. Kornbluh AB; Campano VM; Har C; Dwivedi P; Suslovic W; Sepeta L; Kahn I Mult Scler Relat Disord; 2024 May; 85():105526. PubMed ID: 38489945 [TBL] [Abstract][Full Text] [Related]
31. Progression independent of relapses in aquaporin4-IgG-seropositive neuromyelitis optica spectrum disorder, myelin oligodendrocyte glycoprotein antibody-associated disease, and multiple sclerosis. Molazadeh N; Akaishi T; Bose G; Nishiyama S; Chitnis T; Levy M Mult Scler Relat Disord; 2023 Dec; 80():105093. PubMed ID: 37949025 [TBL] [Abstract][Full Text] [Related]
32. Myelin Oligodendrocyte Glycoprotein-Immunoglobulin G in the CSF: Clinical Implication of Testing and Association With Disability. Kwon YN; Kim B; Kim JS; Mo H; Choi K; Oh SI; Kim JE; Nam TS; Sohn EH; Heo SH; Kim SB; Park KC; Yoon SS; Oh J; Baek SH; Kim BJ; Park KS; Sung JJ; Jung JH; Kim SJ; Park SH; Waters P; Kim SM Neurol Neuroimmunol Neuroinflamm; 2022 Jan; 9(1):. PubMed ID: 34711644 [TBL] [Abstract][Full Text] [Related]
33. MOG and AQP4 Antibodies among Children with Multiple Sclerosis and Controls. Gaudioso CM; Mar S; Casper TC; Codden R; Nguyen A; Aaen G; Benson L; Chitnis T; Francisco C; Gorman MP; Goyal MS; Graves J; Greenberg BM; Hart J; Krupp L; Lotze T; Narula S; Pittock SJ; Rensel M; Rodriguez M; Rose J; Schreiner T; Tillema JM; Waldman A; Weinstock-Guttman B; Wheeler Y; Waubant E; Flanagan EP; Ann Neurol; 2023 Feb; 93(2):271-284. PubMed ID: 36088544 [TBL] [Abstract][Full Text] [Related]
34. Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD): A Review of Clinical and MRI Features, Diagnosis, and Management. Sechi E; Cacciaguerra L; Chen JJ; Mariotto S; Fadda G; Dinoto A; Lopez-Chiriboga AS; Pittock SJ; Flanagan EP Front Neurol; 2022; 13():885218. PubMed ID: 35785363 [TBL] [Abstract][Full Text] [Related]